Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1982 Sep;196(3):305–315. doi: 10.1097/00000658-198209000-00009

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.

S A Rosenberg, J Tepper, E Glatstein, J Costa, A Baker, M Brennan, E V DeMoss, C Seipp, W F Sindelar, P Sugarbaker, R Wesley
PMCID: PMC1352604  PMID: 7114936

Abstract

Between May 1975 and April 1981, 43 adult patients with high-grade soft tissue sarcomas of the extremities were prospectively randomized to receive either amputation at or above the joint proximal to the tumor, including all involved muscle groups, or to receive a limb-sparing resection plus adjuvant radiation therapy. The limb-sparing resection group received wide local excision followed by 5000 rads to the entire anatomic area at risk for local spread and 6000 to 7000 rads to the tumor bed. Both randomization groups received postoperative chemotherapy with doxorubicin (maximum cumulative dose 550 mg/m2), cyclophosphamide, and high-dose methotrexate. Twenty-seven patients randomized to receive limb-sparing resection and radiotherapy, and 16 received amputation (randomization was 2:1). There were four local recurrences in the limb-sparing group and none in the amputation group (p1 = 0.06 generalized Wilcoxon test). However, there were no differences in disease-free survival rates (71% and 78% at five years; p2 = 0.75) or overall survival rates (83% and 88% at five years; p2 = 0.99) between the limb-sparing group and the amputation treatment groups. Multivariate analysis indicated that the only correlate of local recurrence was the final margin of resection. Patients with positive margins of resection had a higher likelihood of local recurrence compared with those with negative margins (p1 less than 0.0001) even when postoperative radiotherapy was used. A simultaneous prospective randomized study of postoperative chemotherapy in 65 patients with high-grade soft-tissue sarcomas of the extremities revealed a marked advantage in patients receiving chemotherapy compared with those without chemotherapy in three-year continuous disease-free (92% vs. 60%; p1 = 0.0008) and overall survival (95% vs. 74%; p1 = 0.04). Thus limb-sparing surgery, radiation therapy, and adjuvant chemotherapy appear capable of successfully treating the great majority of adult patients with soft tissue sarcomas of the extremity.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cantin J., McNeer G. P., Chu F. C., Booher R. J. The problem of local recurrence after treatment of soft tissue sarcoma. Ann Surg. 1968 Jul;168(1):47–53. doi: 10.1097/00000658-196807000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gerner R. E., Moore G. E., Pickren J. W. Soft tissue sarcomas. Ann Surg. 1975 Jun;181(6):803–808. doi: 10.1097/00000658-197506000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gottlieb J. A., Benjamin R. S., Baker L. H., O'Bryan R. M., Sinkovics J. G., Hoogstraten B., Quagliana J. M., Rivkin S. E., Bodey G. P., Sr, Rodriguez V. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep. 1976 Feb;60(2):199–203. [PubMed] [Google Scholar]
  4. HARE H. F., CERNY M. J., Jr SOFT TISSUE SARCOMA. A REVIEW OF 200 CASES. Cancer. 1963 Oct;16:1332–1337. doi: 10.1002/1097-0142(196310)16:10<1332::aid-cncr2820161014>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  5. Lindberg R. D., Martin R. G., Romsdahl M. M. Surgery and postoperative radiotherapy in the treatment of soft tissue sarcomas in adults. Am J Roentgenol Radium Ther Nucl Med. 1975 Jan;123(1):123–129. doi: 10.2214/ajr.123.1.123. [DOI] [PubMed] [Google Scholar]
  6. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  7. O'Bryan R. M., Baker L. H., Gottlieb J. E., Rivkin S. E., Balcerzak S. P., Grumet G. N., Salmon S. E., Moon T. E., Hoogstraten B. Dose response evaluation of adriamycin in human neoplasia. Cancer. 1977 May;39(5):1940–1948. doi: 10.1002/1097-0142(197705)39:5<1940::aid-cncr2820390505>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  8. O'Bryan R. M., Luce J. K., Talley R. W., Gottlieb J. A., Baker L. H., Bonadonna G. Phase II evaluation of adriamycin in human neoplasia. Cancer. 1973 Jul;32(1):1–8. doi: 10.1002/1097-0142(197307)32:1<1::aid-cncr2820320101>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rosenberg S. A., Glatstein E. J. Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities. Semin Oncol. 1981 Jun;8(2):190–200. [PubMed] [Google Scholar]
  11. Rosenberg S. A., Kent H., Costa J., Webber B. L., Young R., Chabner B., Baker A. R., Brennan M. F., Chretien P. B., Cohen M. H. Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery. 1978 Jul;84(1):62–69. [PubMed] [Google Scholar]
  12. SHIEBER W., GRAHAM P. An experience with sarcomas of the soft tissues in adults. Surgery. 1962 Aug;52:295–298. [PubMed] [Google Scholar]
  13. Selawry O. S., Holland J. F., Wolman I. J. Effect of vincristine (NSC-67574) on malignant solid tumors in children. Cancer Chemother Rep. 1968 Jun;52(4):497–500. [PubMed] [Google Scholar]
  14. Shiu M. H., Castro E. B., Hajdu S. I., Fortner J. G. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975 Nov;182(5):597–602. doi: 10.1097/00000658-197511000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Simon M. A., Enneking W. F. The management of soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1976 Apr;58(3):317–327. [PubMed] [Google Scholar]
  16. Subramanian S., Wiltshaw E. Chemotherapy of sarcoma. A comparison of three regimens. Lancet. 1978 Apr 1;1(8066):683–686. doi: 10.1016/s0140-6736(78)90798-5. [DOI] [PubMed] [Google Scholar]
  17. Sugarbaker P. H., Barofsky I., Rosenberg S. A., Gianola F. J. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery. 1982 Jan;91(1):17–23. [PubMed] [Google Scholar]
  18. Suit H. D., Russell W. O., Martin R. G. Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer. 1975 May;35(5):1478–1483. doi: 10.1002/1097-0142(197505)35:5<1478::aid-cncr2820350537>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  19. Tepper J., Rosenberg S. A., Glatstein E. Radiation therapy technique in soft tissue sarcomas of the extremity--policies of treatment at the National Cancer Institute. Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):263–273. doi: 10.1016/0360-3016(82)90526-0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES